Categories

R&D Ashes: Is the UK Losing the Series?

Recently I spoke with two international businesses, one Dutch and one Korean. Both were involved in oncology clinical trials. Both were deciding where to run the next phase of development.

Read More

R&D Tax Relief in 2025 review

As 2025 draws to a close, it is clear that this has been one of the most consequential years for UK R&D tax relief since the original SME and RDEC

Read More